Global Dendritic Cell Cancer Vaccines Market Insights and Forecast to 2028

Report ID: 1802552 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 CreaVax
        1.2.3 Sipuleucel-T (Provenge)
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Pediatrics
        1.3.3 Adults
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Dendritic Cell Cancer Vaccines Market Perspective (2017-2028)
    2.2 Dendritic Cell Cancer Vaccines Growth Trends by Region
        2.2.1 Dendritic Cell Cancer Vaccines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Dendritic Cell Cancer Vaccines Historic Market Size by Region (2017-2022)
        2.2.3 Dendritic Cell Cancer Vaccines Forecasted Market Size by Region (2023-2028)
    2.3 Dendritic Cell Cancer Vaccines Market Dynamics
        2.3.1 Dendritic Cell Cancer Vaccines Industry Trends
        2.3.2 Dendritic Cell Cancer Vaccines Market Drivers
        2.3.3 Dendritic Cell Cancer Vaccines Market Challenges
        2.3.4 Dendritic Cell Cancer Vaccines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Dendritic Cell Cancer Vaccines Players by Revenue
        3.1.1 Global Top Dendritic Cell Cancer Vaccines Players by Revenue (2017-2022)
        3.1.2 Global Dendritic Cell Cancer Vaccines Revenue Market Share by Players (2017-2022)
    3.2 Global Dendritic Cell Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Dendritic Cell Cancer Vaccines Revenue
    3.4 Global Dendritic Cell Cancer Vaccines Market Concentration Ratio
        3.4.1 Global Dendritic Cell Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Dendritic Cell Cancer Vaccines Revenue in 2021
    3.5 Dendritic Cell Cancer Vaccines Key Players Head office and Area Served
    3.6 Key Players Dendritic Cell Cancer Vaccines Product Solution and Service
    3.7 Date of Enter into Dendritic Cell Cancer Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Dendritic Cell Cancer Vaccines Breakdown Data by Type
    4.1 Global Dendritic Cell Cancer Vaccines Historic Market Size by Type (2017-2022)
    4.2 Global Dendritic Cell Cancer Vaccines Forecasted Market Size by Type (2023-2028)
5 Dendritic Cell Cancer Vaccines Breakdown Data by Application
    5.1 Global Dendritic Cell Cancer Vaccines Historic Market Size by Application (2017-2022)
    5.2 Global Dendritic Cell Cancer Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Dendritic Cell Cancer Vaccines Market Size (2017-2028)
    6.2 North America Dendritic Cell Cancer Vaccines Market Size by Type
        6.2.1 North America Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022)
        6.2.2 North America Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028)
        6.2.3 North America Dendritic Cell Cancer Vaccines Market Share by Type (2017-2028)
    6.3 North America Dendritic Cell Cancer Vaccines Market Size by Application
        6.3.1 North America Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022)
        6.3.2 North America Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028)
        6.3.3 North America Dendritic Cell Cancer Vaccines Market Share by Application (2017-2028)
    6.4 North America Dendritic Cell Cancer Vaccines Market Size by Country
        6.4.1 North America Dendritic Cell Cancer Vaccines Market Size by Country (2017-2022)
        6.4.2 North America Dendritic Cell Cancer Vaccines Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Dendritic Cell Cancer Vaccines Market Size (2017-2028)
    7.2 Europe Dendritic Cell Cancer Vaccines Market Size by Type
        7.2.1 Europe Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022)
        7.2.2 Europe Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028)
        7.2.3 Europe Dendritic Cell Cancer Vaccines Market Share by Type (2017-2028)
    7.3 Europe Dendritic Cell Cancer Vaccines Market Size by Application
        7.3.1 Europe Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022)
        7.3.2 Europe Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028)
        7.3.3 Europe Dendritic Cell Cancer Vaccines Market Share by Application (2017-2028)
    7.4 Europe Dendritic Cell Cancer Vaccines Market Size by Country
        7.4.1 Europe Dendritic Cell Cancer Vaccines Market Size by Country (2017-2022)
        7.4.2 Europe Dendritic Cell Cancer Vaccines Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size (2017-2028)
    8.2 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Type
        8.2.1 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Dendritic Cell Cancer Vaccines Market Share by Type (2017-2028)
    8.3 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Application
        8.3.1 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Dendritic Cell Cancer Vaccines Market Share by Application (2017-2028)
    8.4 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Region
        8.4.1 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Dendritic Cell Cancer Vaccines Market Size (2017-2028)
    9.2 Latin America Dendritic Cell Cancer Vaccines Market Size by Type
        9.2.1 Latin America Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022)
        9.2.2 Latin America Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028)
        9.2.3 Latin America Dendritic Cell Cancer Vaccines Market Share by Type (2017-2028)
    9.3 Latin America Dendritic Cell Cancer Vaccines Market Size by Application
        9.3.1 Latin America Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022)
        9.3.2 Latin America Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028)
        9.3.3 Latin America Dendritic Cell Cancer Vaccines Market Share by Application (2017-2028)
    9.4 Latin America Dendritic Cell Cancer Vaccines Market Size by Country
        9.4.1 Latin America Dendritic Cell Cancer Vaccines Market Size by Country (2017-2022)
        9.4.2 Latin America Dendritic Cell Cancer Vaccines Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size (2017-2028)
    10.2 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Type
        10.2.1 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Dendritic Cell Cancer Vaccines Market Share by Type (2017-2028)
    10.3 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Application
        10.3.1 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Dendritic Cell Cancer Vaccines Market Share by Application (2017-2028)
    10.4 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Country
        10.4.1 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 3M Company
        11.1.1 3M Company Company Details
        11.1.2 3M Company Business Overview
        11.1.3 3M Company Dendritic Cell Cancer Vaccines Introduction
        11.1.4 3M Company Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.1.5 3M Company Recent Developments
    11.2 Activarti
        11.2.1 Activarti Company Details
        11.2.2 Activarti Business Overview
        11.2.3 Activarti Dendritic Cell Cancer Vaccines Introduction
        11.2.4 Activarti Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.2.5 Activarti Recent Developments
    11.3 Argos Therapeutics
        11.3.1 Argos Therapeutics Company Details
        11.3.2 Argos Therapeutics Business Overview
        11.3.3 Argos Therapeutics Dendritic Cell Cancer Vaccines Introduction
        11.3.4 Argos Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.3.5 Argos Therapeutics Recent Developments
    11.4 Batavia Bioservices
        11.4.1 Batavia Bioservices Company Details
        11.4.2 Batavia Bioservices Business Overview
        11.4.3 Batavia Bioservices Dendritic Cell Cancer Vaccines Introduction
        11.4.4 Batavia Bioservices Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.4.5 Batavia Bioservices Recent Developments
    11.5 Bellicum Pharmaceuticals
        11.5.1 Bellicum Pharmaceuticals Company Details
        11.5.2 Bellicum Pharmaceuticals Business Overview
        11.5.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccines Introduction
        11.5.4 Bellicum Pharmaceuticals Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.5.5 Bellicum Pharmaceuticals Recent Developments
    11.6 Creagene
        11.6.1 Creagene Company Details
        11.6.2 Creagene Business Overview
        11.6.3 Creagene Dendritic Cell Cancer Vaccines Introduction
        11.6.4 Creagene Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.6.5 Creagene Recent Developments
    11.7 DanDrit Biotech
        11.7.1 DanDrit Biotech Company Details
        11.7.2 DanDrit Biotech Business Overview
        11.7.3 DanDrit Biotech Dendritic Cell Cancer Vaccines Introduction
        11.7.4 DanDrit Biotech Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.7.5 DanDrit Biotech Recent Developments
    11.8 DCPrime
        11.8.1 DCPrime Company Details
        11.8.2 DCPrime Business Overview
        11.8.3 DCPrime Dendritic Cell Cancer Vaccines Introduction
        11.8.4 DCPrime Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.8.5 DCPrime Recent Developments
    11.9 Sanpower Corporation
        11.9.1 Sanpower Corporation Company Details
        11.9.2 Sanpower Corporation Business Overview
        11.9.3 Sanpower Corporation Dendritic Cell Cancer Vaccines Introduction
        11.9.4 Sanpower Corporation Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.9.5 Sanpower Corporation Recent Developments
    11.10 Elios Therapeutics
        11.10.1 Elios Therapeutics Company Details
        11.10.2 Elios Therapeutics Business Overview
        11.10.3 Elios Therapeutics Dendritic Cell Cancer Vaccines Introduction
        11.10.4 Elios Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.10.5 Elios Therapeutics Recent Developments
    11.11 ImmunoCellular Therapeutics
        11.11.1 ImmunoCellular Therapeutics Company Details
        11.11.2 ImmunoCellular Therapeutics Business Overview
        11.11.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccines Introduction
        11.11.4 ImmunoCellular Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.11.5 ImmunoCellular Therapeutics Recent Developments
    11.12 Immunicum
        11.12.1 Immunicum Company Details
        11.12.2 Immunicum Business Overview
        11.12.3 Immunicum Dendritic Cell Cancer Vaccines Introduction
        11.12.4 Immunicum Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.12.5 Immunicum Recent Developments
    11.13 Kiromic
        11.13.1 Kiromic Company Details
        11.13.2 Kiromic Business Overview
        11.13.3 Kiromic Dendritic Cell Cancer Vaccines Introduction
        11.13.4 Kiromic Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.13.5 Kiromic Recent Developments
    11.14 Medigene
        11.14.1 Medigene Company Details
        11.14.2 Medigene Business Overview
        11.14.3 Medigene Dendritic Cell Cancer Vaccines Introduction
        11.14.4 Medigene Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.14.5 Medigene Recent Developments
    11.15 Merck
        11.15.1 Merck Company Details
        11.15.2 Merck Business Overview
        11.15.3 Merck Dendritic Cell Cancer Vaccines Introduction
        11.15.4 Merck Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.15.5 Merck Recent Developments
    11.16 Northwest Biotherapeutics
        11.16.1 Northwest Biotherapeutics Company Details
        11.16.2 Northwest Biotherapeutics Business Overview
        11.16.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccines Introduction
        11.16.4 Northwest Biotherapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.16.5 Northwest Biotherapeutics Recent Developments
    11.17 Glaxo Smith Kline
        11.17.1 Glaxo Smith Kline Company Details
        11.17.2 Glaxo Smith Kline Business Overview
        11.17.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccines Introduction
        11.17.4 Glaxo Smith Kline Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.17.5 Glaxo Smith Kline Recent Developments
    11.18 Tellaorporation
        11.18.1 Tellaorporation Company Details
        11.18.2 Tellaorporation Business Overview
        11.18.3 Tellaorporation Dendritic Cell Cancer Vaccines Introduction
        11.18.4 Tellaorporation Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.18.5 Tellaorporation Recent Developments
    11.19 Vaxil BioTherapeutics
        11.19.1 Vaxil BioTherapeutics Company Details
        11.19.2 Vaxil BioTherapeutics Business Overview
        11.19.3 Vaxil BioTherapeutics Dendritic Cell Cancer Vaccines Introduction
        11.19.4 Vaxil BioTherapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022)
        11.19.5 Vaxil BioTherapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of CreaVax
    Table 3. Key Players of Sipuleucel-T (Provenge)
    Table 4. Key Players of Others
    Table 5. Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Dendritic Cell Cancer Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Dendritic Cell Cancer Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Dendritic Cell Cancer Vaccines Market Share by Region (2017-2022)
    Table 9. Global Dendritic Cell Cancer Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Dendritic Cell Cancer Vaccines Market Share by Region (2023-2028)
    Table 11. Dendritic Cell Cancer Vaccines Market Trends
    Table 12. Dendritic Cell Cancer Vaccines Market Drivers
    Table 13. Dendritic Cell Cancer Vaccines Market Challenges
    Table 14. Dendritic Cell Cancer Vaccines Market Restraints
    Table 15. Global Dendritic Cell Cancer Vaccines Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Dendritic Cell Cancer Vaccines Revenue Share by Players (2017-2022)
    Table 17. Global Top Dendritic Cell Cancer Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dendritic Cell Cancer Vaccines as of 2021)
    Table 18. Ranking of Global Top Dendritic Cell Cancer Vaccines Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Dendritic Cell Cancer Vaccines Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Dendritic Cell Cancer Vaccines Product Solution and Service
    Table 22. Date of Enter into Dendritic Cell Cancer Vaccines Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Dendritic Cell Cancer Vaccines Revenue Market Share by Type (2017-2022)
    Table 26. Global Dendritic Cell Cancer Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Dendritic Cell Cancer Vaccines Revenue Market Share by Type (2023-2028)
    Table 28. Global Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Dendritic Cell Cancer Vaccines Revenue Share by Application (2017-2022)
    Table 30. Global Dendritic Cell Cancer Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Dendritic Cell Cancer Vaccines Revenue Share by Application (2023-2028)
    Table 32. North America Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Dendritic Cell Cancer Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Dendritic Cell Cancer Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Dendritic Cell Cancer Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Dendritic Cell Cancer Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Dendritic Cell Cancer Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Dendritic Cell Cancer Vaccines Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Dendritic Cell Cancer Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Dendritic Cell Cancer Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Dendritic Cell Cancer Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Dendritic Cell Cancer Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Dendritic Cell Cancer Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Dendritic Cell Cancer Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Dendritic Cell Cancer Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Dendritic Cell Cancer Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 62. 3M Company Company Details
    Table 63. 3M Company Business Overview
    Table 64. 3M Company Dendritic Cell Cancer Vaccines Product
    Table 65. 3M Company Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 66. 3M Company Recent Developments
    Table 67. Activarti Company Details
    Table 68. Activarti Business Overview
    Table 69. Activarti Dendritic Cell Cancer Vaccines Product
    Table 70. Activarti Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 71. Activarti Recent Developments
    Table 72. Argos Therapeutics Company Details
    Table 73. Argos Therapeutics Business Overview
    Table 74. Argos Therapeutics Dendritic Cell Cancer Vaccines Product
    Table 75. Argos Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 76. Argos Therapeutics Recent Developments
    Table 77. Batavia Bioservices Company Details
    Table 78. Batavia Bioservices Business Overview
    Table 79. Batavia Bioservices Dendritic Cell Cancer Vaccines Product
    Table 80. Batavia Bioservices Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 81. Batavia Bioservices Recent Developments
    Table 82. Bellicum Pharmaceuticals Company Details
    Table 83. Bellicum Pharmaceuticals Business Overview
    Table 84. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccines Product
    Table 85. Bellicum Pharmaceuticals Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 86. Bellicum Pharmaceuticals Recent Developments
    Table 87. Creagene Company Details
    Table 88. Creagene Business Overview
    Table 89. Creagene Dendritic Cell Cancer Vaccines Product
    Table 90. Creagene Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 91. Creagene Recent Developments
    Table 92. DanDrit Biotech Company Details
    Table 93. DanDrit Biotech Business Overview
    Table 94. DanDrit Biotech Dendritic Cell Cancer Vaccines Product
    Table 95. DanDrit Biotech Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 96. DanDrit Biotech Recent Developments
    Table 97. DCPrime Company Details
    Table 98. DCPrime Business Overview
    Table 99. DCPrime Dendritic Cell Cancer Vaccines Product
    Table 100. DCPrime Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 101. DCPrime Recent Developments
    Table 102. Sanpower Corporation Company Details
    Table 103. Sanpower Corporation Business Overview
    Table 104. Sanpower Corporation Dendritic Cell Cancer Vaccines Product
    Table 105. Sanpower Corporation Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 106. Sanpower Corporation Recent Developments
    Table 107. Elios Therapeutics Company Details
    Table 108. Elios Therapeutics Business Overview
    Table 109. Elios Therapeutics Dendritic Cell Cancer Vaccines Product
    Table 110. Elios Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 111. Elios Therapeutics Recent Developments
    Table 112. ImmunoCellular Therapeutics Company Details
    Table 113. ImmunoCellular Therapeutics Business Overview
    Table 114. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccines Product
    Table 115. ImmunoCellular Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 116. ImmunoCellular Therapeutics Recent Developments
    Table 117. Immunicum Company Details
    Table 118. Immunicum Business Overview
    Table 119. Immunicum Dendritic Cell Cancer Vaccines Product
    Table 120. Immunicum Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 121. Immunicum Recent Developments
    Table 122. Kiromic Company Details
    Table 123. Kiromic Business Overview
    Table 124. Kiromic Dendritic Cell Cancer Vaccines Product
    Table 125. Kiromic Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 126. Kiromic Recent Developments
    Table 127. Medigene Company Details
    Table 128. Medigene Business Overview
    Table 129. Medigene Dendritic Cell Cancer Vaccines Product
    Table 130. Medigene Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 131. Medigene Recent Developments
    Table 132. Merck Company Details
    Table 133. Merck Business Overview
    Table 134. Merck Dendritic Cell Cancer Vaccines Product
    Table 135. Merck Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 136. Merck Recent Developments
    Table 137. Northwest Biotherapeutics Company Details
    Table 138. Northwest Biotherapeutics Business Overview
    Table 139. Northwest Biotherapeutics Dendritic Cell Cancer Vaccines Product
    Table 140. Northwest Biotherapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 141. Northwest Biotherapeutics Recent Developments
    Table 142. Glaxo Smith Kline Company Details
    Table 143. Glaxo Smith Kline Business Overview
    Table 144. Glaxo Smith Kline Dendritic Cell Cancer Vaccines Product
    Table 145. Glaxo Smith Kline Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 146. Glaxo Smith Kline Recent Developments
    Table 147. Tellaorporation Company Details
    Table 148. Tellaorporation Business Overview
    Table 149. Tellaorporation Dendritic Cell Cancer Vaccines Product
    Table 150. Tellaorporation Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 151. Tellaorporation Recent Developments
    Table 152. Vaxil BioTherapeutics Company Details
    Table 153. Vaxil BioTherapeutics Business Overview
    Table 154. Vaxil BioTherapeutics Dendritic Cell Cancer Vaccines Product
    Table 155. Vaxil BioTherapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2017-2022) & (US$ Million)
    Table 156. Vaxil BioTherapeutics Recent Developments
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dendritic Cell Cancer Vaccines Market Share by Type: 2021 VS 2028
    Figure 2. CreaVax Features
    Figure 3. Sipuleucel-T (Provenge) Features
    Figure 4. Others Features
    Figure 5. Global Dendritic Cell Cancer Vaccines Market Share by Application: 2021 VS 2028
    Figure 6. Pediatrics Case Studies
    Figure 7. Adults Case Studies
    Figure 8. Dendritic Cell Cancer Vaccines Report Years Considered
    Figure 9. Global Dendritic Cell Cancer Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Dendritic Cell Cancer Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Dendritic Cell Cancer Vaccines Market Share by Region: 2021 VS 2028
    Figure 12. Global Dendritic Cell Cancer Vaccines Market Share by Players in 2021
    Figure 13. Global Top Dendritic Cell Cancer Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dendritic Cell Cancer Vaccines as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Dendritic Cell Cancer Vaccines Revenue in 2021
    Figure 15. North America Dendritic Cell Cancer Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Dendritic Cell Cancer Vaccines Market Size Market Share by Type (2017-2028)
    Figure 17. North America Dendritic Cell Cancer Vaccines Market Size Market Share by Application (2017-2028)
    Figure 18. North America Dendritic Cell Cancer Vaccines Market Size Share by Country (2017-2028)
    Figure 19. United States Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Dendritic Cell Cancer Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Dendritic Cell Cancer Vaccines Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Dendritic Cell Cancer Vaccines Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Dendritic Cell Cancer Vaccines Market Size Share by Country (2017-2028)
    Figure 25. Germany Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Dendritic Cell Cancer Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Dendritic Cell Cancer Vaccines Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Dendritic Cell Cancer Vaccines Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Dendritic Cell Cancer Vaccines Market Size Share by Region (2017-2028)
    Figure 35. China Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Dendritic Cell Cancer Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Dendritic Cell Cancer Vaccines Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Dendritic Cell Cancer Vaccines Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Dendritic Cell Cancer Vaccines Market Size Share by Country (2017-2028)
    Figure 45. Mexico Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Dendritic Cell Cancer Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Dendritic Cell Cancer Vaccines Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Dendritic Cell Cancer Vaccines Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Dendritic Cell Cancer Vaccines Market Size Share by Country (2017-2028)
    Figure 51. Turkey Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Dendritic Cell Cancer Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. 3M Company Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 55. Activarti Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 56. Argos Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 57. Batavia Bioservices Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 58. Bellicum Pharmaceuticals Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 59. Creagene Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 60. DanDrit Biotech Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 61. DCPrime Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 62. Sanpower Corporation Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 63. Elios Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 64. ImmunoCellular Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 65. Immunicum Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 66. Kiromic Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 67. Medigene Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 68. Merck Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 69. Northwest Biotherapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 70. Glaxo Smith Kline Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 71. Tellaorporation Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 72. Vaxil BioTherapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
3M Company
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
Tellaorporation
Vaxil BioTherapeutics
Frequently Asked Questions
Dendritic Cell Cancer Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dendritic Cell Cancer Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dendritic Cell Cancer Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Telepathology

Telepathology market is segmented by players, region (country), by Type and by Application. Playe ... Read More

Spinal Intervention

Spinal Intervention market is segmented by players, region (country), by Type and by Application. ... Read More